GLA and Fabry disease: In this study, we report a novel pathogenic variant, identified through the sequencing of the GLA gene, in two members of a family who presented classic clinical manifestations of Fabry disease, reduced enzyme activity and the presence of elevated Lyso-Gb3 in the blood.